Kulkarni Samarthinsider trades
In SEC Form 4 filings, Kulkarni Samarth is listed as Chief Executive Officer of CRISPR Therapeutics AG (CRSP). In the last 90 days, Kulkarni Samarth sold $2.58M of CRISPR Therapeutics AG (CRSP) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| CRSPCRISPR Therapeutics AG | Chief Executive Officer | 6 | Oct 20 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-15
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| CRSPCRISPR Therapeutics AG | Oct 19 | Oct 20 | S | 47,837 | $49.78 | Sale −$2,381,326 | 311,899 | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Oct 16 | Oct 20 | M | 100,000 | not reported | not reported | 359,736 | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Oct 16 | Oct 20 | M · derivative | 100,000 | not reported | not reported | 200,000 | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Oct 14 | Oct 15 | S | 4,098 | $49.26 | Sale −$201,867 | 259,736 | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Oct 13 | Oct 15 | M | 8,333 | not reported | not reported | 263,834 | No | Form 4 |
| CRSPCRISPR Therapeutics AG | Oct 13 | Oct 15 | M · derivative | 8,333 | not reported | not reported | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.